Camber launches generic Nexium

PISCATAWAY, N.J. — Camber Pharmaceuticals on Wednesday announced the launch of its generic version of Nexium (esomeprazole magnesium) delayed-release capsules. The launch comes after Camber’s parent company, Hetero Labs received final approval from the Food and Drug Administration.

“Esomeprazole represents another very significant product in the growth of our organization, Camber president Kon Ostaficiuk said. “We are happy that patients have a more affordable treatment option.” 

The drug is meant to treat heartburn, stomach ulcers, gastroesophageal reflux disease, and a damaged esophagus. It will be available in 20- and 40-mg capsules, both of which will be available in bottles of 30, 90 and 1000.